Physician Assistant · Ann Arbor, MI
NPI
1629273990
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
164 services
Medicare patients, 2024
53
Average age 69
Drug cost, 2024
$2.5M
525 prescriptions
Company payments, 2024
$120
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irene A Ryan was code 99215 (office e&m - established), 91 times for 40 patients. In total Irene A Ryan billed 164 services in 8 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 91 | 40 | $91.74 | $8,348 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 38 | 24 | $11.17 | $424 |
| 38222 Other Organ Systems | Facility | 21 | 17 | $50.89 | $1,069 |
By year: 2022 $16K for 206 services; 2023 $13K for 174 services; 2024 $10K for 164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Irene A Ryan prescribed most often to Medicare patients was Acyclovir, with 125 prescriptions and refills. In total Irene A Ryan wrote 525 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 125 | 151 | 26 | $1,217 |
| Posaconazole Generic | 46 | 46 | Under 11 | $43K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 38 | Under 11 | $78.5 |
| Venclexta Venetoclax | 35 | 35 | 12 | $88K |
| Sprycel Dasatinib | 24 | 24 | Under 11 | $277K |
| Prednisone Generic | 23 | 25 | Under 11 | $77.61 |
| Tibsovo Ivosidenib | 23 | 23 | Under 11 | $754K |
| Mercaptopurine Generic | 16 | 18 | Under 11 | $1,329 |
| Cyclosporine Modified Cyclosporine, Modified | 15 | 21 | Under 11 | $1,817 |
| Imatinib Mesylate Generic | 14 | 14 | Under 11 | $941 |
| Bosulif Bosutinib | 13 | 13 | Under 11 | $237K |
| Promacta Eltrombopag Olamine | 12 | 12 | Under 11 | $227K |
| Sorafenib Sorafenib Tosylate | 12 | 12 | Under 11 | $74K |
| Levofloxacin Generic | 12 | 12 | Under 11 | $81.6 |
| Rydapt Midostaurin | 11 | 11 | Under 11 | $240K |
Brand drugs: 147 claims; generic drugs: 378 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Irene A Ryan $120 ($120 in general payments such as food, travel and fees) from 1 company. The largest payer was Sobi, Inc with $120.
| Company | Payments | Amount |
|---|---|---|
| Sobi, Inc SOBI.ST | 1 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.